International Conference on Cancer Biomarkers
Conference Series Ltd invites all the participants from all over the world to attend “International Conference on Cancer Biomarkers “to be held on October 26-28, 2017, at Osaka, Japan with the main theme “Innovation and Implementation: Cancer Treatment”
Biomarkers Congress 2017, in the hands of clinical investigators, provide a dynamic and powerful approach to understanding the spectrum of diseases with obvious applications in analytic epidemiology, biomarkers and clinical research in disease prevention, diagnosis, and disease management. Cancer biomarkers have the additional potential to identify individuals susceptible to disease. There is a good scope to know more in this Biomarker Congress In the recent years, the information about cancer biomarkers has increased largely providing great scope for improving the management of cancer patients by improving the accuracy of detection and efficacy of treatment. Latest technological advancement has enabled the examination of many possible biomarkers and renewed interest in developing new biomarkers. All such developments can be evidenced in this Cancer biomarker conference.
An encyclopedic discussion about the significance of each biomarker like toxic dynamics and pharmacodynamics of protein biomarkers, analytical biomarkers, and epigenetic biomarkers is going to take place in the biomarkers congress. This conference also includes both symposiums and workshop events.